Targeted screening of genetic associations with COVID-19 susceptibility and severity. | Front Genet;13: 1073880, 2022. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

Targeted screening of genetic associations with COVID-19 susceptibility and severity.

Li, Ping; Ke, Yuehua; Shen, Wenlong; Shi, Shu; Wang, Yahao; Lin, Kailin; Guo, Xinjie; Wang, Changjun; Zhang, Yan; Zhao, Zhihu.

Afiliação

Li P; Beijing Institute of Biotechnology, Beijing, China.
Ke Y; Center for Disease Control and Prevention of PLA, Beijing, China.
Shen W; Beijing Institute of Biotechnology, Beijing, China.
Shi S; Beijing Institute of Biotechnology, Beijing, China.
Wang Y; Beijing Institute of Biotechnology, Beijing, China.
Lin K; College of Life Science, Henan Normal University, Xinxiang, China.
Guo X; Beijing Institute of Biotechnology, Beijing, China.
Wang C; Center for Disease Control and Prevention of PLA, Beijing, China.
Zhang Y; Beijing Institute of Biotechnology, Beijing, China.
Zhao Z; Beijing Institute of Biotechnology, Beijing, China.

Front Genet ; 13: 1073880, 2022.

Article em En | MEDLINE | ID: mdl-36531218

Palavras-chave

COVID-19; SARS-CoV-2; SNP; enhancer; genetic variant; suscepibility; targeted capture sequencing

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article